ZA971659B - Erythromycin derivatives, their preparation process and their use as medicaments. - Google Patents

Erythromycin derivatives, their preparation process and their use as medicaments.

Info

Publication number
ZA971659B
ZA971659B ZA9701659A ZA971659A ZA971659B ZA 971659 B ZA971659 B ZA 971659B ZA 9701659 A ZA9701659 A ZA 9701659A ZA 971659 A ZA971659 A ZA 971659A ZA 971659 B ZA971659 B ZA 971659B
Authority
ZA
South Africa
Prior art keywords
medicaments
preparation process
erythromycin derivatives
erythromycin
derivatives
Prior art date
Application number
ZA9701659A
Other languages
English (en)
Inventor
Constantin Agouridas
Jean-Francois Chantot
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of ZA971659B publication Critical patent/ZA971659B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
ZA9701659A 1996-02-28 1997-02-26 Erythromycin derivatives, their preparation process and their use as medicaments. ZA971659B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9602472A FR2745290B1 (fr) 1996-02-28 1996-02-28 Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Publications (1)

Publication Number Publication Date
ZA971659B true ZA971659B (en) 1998-02-26

Family

ID=9489659

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9701659A ZA971659B (en) 1996-02-28 1997-02-26 Erythromycin derivatives, their preparation process and their use as medicaments.

Country Status (31)

Country Link
US (1) US6096714A (ko)
EP (1) EP0885234B1 (ko)
JP (1) JP4102440B2 (ko)
KR (1) KR100486053B1 (ko)
CN (1) CN1168734C (ko)
AP (1) AP952A (ko)
AR (1) AR005999A1 (ko)
AT (1) ATE217633T1 (ko)
AU (1) AU716204B2 (ko)
BG (1) BG63207B1 (ko)
BR (1) BR9707709B1 (ko)
CZ (1) CZ293893B6 (ko)
DE (1) DE69712610T2 (ko)
DK (1) DK0885234T3 (ko)
EA (1) EA001376B1 (ko)
EE (1) EE9800265A (ko)
ES (1) ES2176698T3 (ko)
FR (1) FR2745290B1 (ko)
HU (1) HU227567B1 (ko)
IL (1) IL125622A (ko)
NO (1) NO983955D0 (ko)
NZ (1) NZ331600A (ko)
OA (1) OA10845A (ko)
PL (1) PL191736B1 (ko)
PT (1) PT885234E (ko)
SK (1) SK118498A3 (ko)
TR (1) TR199801713T2 (ko)
UA (1) UA58504C2 (ko)
WO (1) WO1997031929A1 (ko)
YU (1) YU37098A (ko)
ZA (1) ZA971659B (ko)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA989835B (en) * 1997-10-29 1999-05-05 Taisho Pharmaceutical Co Ltd Erythromycin a derivatives
AU9649698A (en) * 1997-10-29 1999-05-17 Taisho Pharmaceutical Co., Ltd. Erythromycin a 11, 12-carbamate derivatives
JP4573925B2 (ja) * 1998-07-09 2010-11-04 アベンティス・ファーマ・ソシエテ・アノニム 新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2792637B1 (fr) * 1999-04-26 2001-06-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2780977B1 (fr) * 1998-07-09 2000-09-01 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2781484B1 (fr) * 1998-07-21 2001-08-10 Hoechst Marion Roussel Inc Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
SI1147121T1 (en) 1999-01-27 2004-04-30 Pfizer Products Inc. Ketolide antibiotics
EE200100613A (et) * 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
WO2001010878A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO2001010880A1 (fr) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Derives d'erythromycine a
WO2001010879A1 (en) * 1999-08-06 2001-02-15 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
EP1146051A3 (en) * 2000-04-10 2001-10-31 Pfizer Products Inc. Erythromycin A derivatives
US20020115621A1 (en) * 2000-08-07 2002-08-22 Wei-Gu Su Macrolide antibiotics
ITMI20021726A1 (it) * 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
EP2772254A3 (en) 2003-03-10 2015-03-11 Optimer Pharmaceuticals, Inc. Novel Antibacterial Agents
US20050014706A1 (en) * 2003-07-14 2005-01-20 Kanakeshwari Falzari Method of treating tuberculosis
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
JP5698979B2 (ja) * 2007-10-25 2015-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド系抗菌剤の調製プロセス
CN105616437A (zh) * 2008-10-24 2016-06-01 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
CN108310000A (zh) 2009-09-10 2018-07-24 森普拉制药公司 治疗疟疾、结核病和mac疾病的方法
EP3009442B1 (en) 2010-03-22 2019-06-19 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
DK2571506T3 (en) 2010-05-20 2017-08-28 Cempra Pharmaceuticals Inc PROCEDURES FOR THE MANUFACTURE OF MACROLIDES AND KETOLIDES AND INTERMEDIATES
US9815863B2 (en) 2010-09-10 2017-11-14 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
RU2658050C2 (ru) 2012-03-27 2018-06-19 Семпра Фармасьютикалз, Инк. Парентеральные составы для введения макролидных антибиотиков
JP6426696B2 (ja) 2013-03-14 2018-11-21 センプラ ファーマシューティカルズ，インコーポレイテッド 呼吸器疾患の治療のための方法および製剤
CA2907085A1 (en) 2013-03-15 2014-09-18 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US487411A (en) * 1892-12-06 Island
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
US5444031A (en) * 1993-01-21 1995-08-22 Calgon Carbon Corporation Process for making catalytic carbon
FR2727969B1 (fr) * 1994-12-09 1997-01-17 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
CN1168734C (zh) 2004-09-29
OA10845A (fr) 2003-02-05
YU37098A (sh) 1999-07-28
EP0885234B1 (fr) 2002-05-15
FR2745290B1 (fr) 1998-04-03
AP952A (en) 2001-03-29
AU1929897A (en) 1997-09-16
BG102691A (en) 1999-06-30
EA001376B1 (ru) 2001-02-26
PL191736B1 (pl) 2006-06-30
EA199800768A1 (ru) 1999-02-25
NO983955L (no) 1998-08-27
FR2745290A1 (fr) 1997-08-29
CZ258798A3 (cs) 1998-12-16
JP4102440B2 (ja) 2008-06-18
PL328608A1 (en) 1999-02-01
DE69712610T2 (de) 2002-11-28
EP0885234A1 (fr) 1998-12-23
AU716204B2 (en) 2000-02-24
AP9801318A0 (en) 1998-09-30
BG63207B1 (bg) 2001-06-29
SK118498A3 (en) 1999-07-12
HUP9902576A1 (hu) 1999-12-28
NZ331600A (en) 1999-08-30
AR005999A1 (es) 1999-07-21
BR9707709B1 (pt) 2014-10-14
WO1997031929A1 (fr) 1997-09-04
ES2176698T3 (es) 2002-12-01
EE9800265A (et) 1999-02-15
JP2000505469A (ja) 2000-05-09
KR19990087324A (ko) 1999-12-27
UA58504C2 (uk) 2003-08-15
HUP9902576A3 (en) 2001-03-28
HU227567B1 (en) 2011-08-29
CN1212700A (zh) 1999-03-31
ATE217633T1 (de) 2002-06-15
DE69712610D1 (de) 2002-06-20
BR9707709A (pt) 1999-04-06
US6096714A (en) 2000-08-01
PT885234E (pt) 2002-10-31
CZ293893B6 (cs) 2004-08-18
KR100486053B1 (ko) 2005-06-16
IL125622A (en) 2003-10-31
DK0885234T3 (da) 2002-08-26
IL125622A0 (en) 1999-04-11
TR199801713T2 (xx) 1998-12-21
NO983955D0 (no) 1998-08-27

Similar Documents

Publication Publication Date Title
ZA971659B (en) Erythromycin derivatives, their preparation process and their use as medicaments.
AP9500743A0 (en) New erythromycin derivatives, their preparation process and their use as medicaments
AP9500744A0 (en) New erythromycin derivatives, their process and their use as medicaments
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
EP0710667B8 (de) Modifizierte Oligonukleotide, deren Herstellung sowie deren Verwendung
HK1020956A1 (en) Oxadiazoles, processes for their preparation and their use as medicaments
ZA200007638B (en) Pyrazoline derivatives, their preparation and application as medicaments.
PL348098A1 (en) Novel erythromycin derivatives, preparation method and use as medicines
ZA9711317B (en) Substituted purine derivatives, processes for their preparation, their use, and compositions comprising them.
ZA997176B (en) Derivatives of erythromycin, their preparation process and their use as medicaments.
HK1040980A1 (zh) 聯苯磺酰基氨基氰、其製備方法及其作為藥物的用途
EP0599159A3 (de) a-L-Rhamnosidase zur Gewinnung von Rhamnose, ein Verfahren zur Herstellung und ihre Verwendung.
GR3032847T3 (en) 13-Substituted milbemycin derivatives, their preparation and use.
HUP0104620A3 (en) 2-phenylpyran-4-one derivatives, process for their preparation and medicaments containing them
ZA976329B (en) Substituted pyrazolylpyrazole derivatives, process for their preparation, and their use as herbicides.
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
IL130420A (en) Erythromycin derivatives, method for preparing them and their use as medicine
ZA976735B (en) Substituted indanylidineacetylguanidines, process for their preparation, their use as medicaments or diagnostic and medicaments containing them.
SI0863139T1 (en) Benzoxazindione derivatives, process for their preparation and their use
ZA9810403B (en) New epothilon derivatives, process for their preparation and their pharmaceutical use.
EP0583698A3 (en) Deoxy-cyclitol derivatives, process for their preparation and their use in medicaments.
AU2886197A (en) New leukotriene-b4 derivatives, their preparation process and their use as medicaments
HK1034505A1 (en) Triazepinones, process for their preparation and their therapeutic application.
EP0643060A3 (de) Sulfonylbenzyl-substituierte Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.